Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-25 @ 2:39 PM
NCT ID:
NCT02513550
Group ID:
EG001
Title:
80 mg Ixekizumab Q4W/Q2W - Treatment Period
Description:
160 mg ixekizumab given as 2 SQ injections at baseline and then 80 mg ixekizumab given as one SQ injection Q4W with step-up dosing to Q2W as needed (Q4W/Q2W step-up) to week 52. Placebo administered SQ, Q2W to maintain blind.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
306
Other Number Affected:
136
Other Number At Risk:
306
Study:
NCT02513550
Results Section:
NCT02513550
Adverse Events Module:
NCT02513550